Evaluation of EFficacy and SaFEty of Leukotac (Inolimomab) in Pediatric Patients With SR-aGvHD

Clinical trial NCT04289103 · UNKNOWN

Trial details

NCT number: NCT04289103
Sponsor: ElsaLys Biotech
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Steroid Refractory GVHD

Start date: 2021-10-01
Primary completion: 2022-12-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.